HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Instituto Carlos III, Madrid, Spain.
Nat Rev Neurosci. 2022 Feb;23(2):115-128. doi: 10.1038/s41583-021-00542-9. Epub 2021 Dec 14.
For the last two decades, pathogenic concepts in Parkinson disease (PD) have revolved around the toxicity and spread of α-synuclein. Thus, α-synuclein would follow caudo-rostral propagation from the periphery to the central nervous system, first producing non-motor manifestations (such as constipation, sleep disorders and hyposmia), and subsequently impinging upon the mesencephalon to account for the cardinal motor features before reaching the neocortex as the disease evolves towards dementia. This model is the prevailing theory of the principal neurobiological mechanism of disease. Here, we scrutinize the temporal evolution of motor and non-motor manifestations in PD and suggest that, even though the postulated bottom-up mechanisms are likely to be involved, early involvement of the nigrostriatal system is a key and prominent pathophysiological mechanism. Upcoming studies of detailed clinical manifestations with newer neuroimaging techniques will allow us to more closely define, in vivo, the role of α-synuclein aggregates with respect to neuronal loss during the onset and progression of PD.
在过去的二十年中,帕金森病 (PD) 的致病概念围绕着α-突触核蛋白的毒性和扩散展开。因此,α-突触核蛋白会从外周向中枢神经系统进行头尾传播,首先产生非运动症状(如便秘、睡眠障碍和嗅觉减退),随后侵犯中脑,从而解释疾病向痴呆发展过程中的主要运动特征,然后再到达大脑皮层。这个模型是疾病主要神经生物学机制的主流理论。在这里,我们仔细研究了 PD 中运动和非运动症状的时间演变,并提出,尽管假设的自下而上的机制可能涉及其中,但黑质纹状体系统的早期参与是一个关键且突出的病理生理机制。使用新的神经影像学技术对详细的临床表现进行的未来研究将使我们能够更密切地定义,在体内,α-突触核蛋白聚集物在 PD 发作和进展过程中与神经元丧失的关系。